A 70-year-old with AF and prior intracranial hemorrhage now has a left atrial appendage occlusion device placed. Regarding antithrombotics post-implan...

Question

A 70-year-old with AF and prior intracranial hemorrhage now has a left atrial appendage occlusion device placed. Regarding antithrombotics post-implant (assume standard protocol), which principle is true?

Accepted Answer

Short-term antithrombotic therapy transitions to single antiplatelet per device protocol; OAC not always required long-term

Answer

OAC mandatory lifelong

Answer

No antithrombotic therapy ever

Answer

Dual antiplatelet lifelong mandatory

Answer

Aspirin plus OAC lifelong

us-abim MCQ (SBA): Atrial Fibrillation

A 70-year-old with AF and prior intracranial hemorrhage now has a left atrial appendage occlusion device placed. Regarding antithrombotics post-implant (assume standard protocol), which principle is true?